Found: 15
Select item for more details and to access through your institution.
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation—results from four European countries.
- Published in:
- European Journal of Public Health, 2009, v. 19, n. 6, p. 650, doi. 10.1093/eurpub/ckp075
- By:
- Publication type:
- Article
Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 2987, doi. 10.2147/COPD.S381138
- By:
- Publication type:
- Article
Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 427, doi. 10.2147/COPD.S346591
- By:
- Publication type:
- Article
A Systematic Literature Review of the Humanistic Burden of COPD.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1303, doi. 10.2147/COPD.S296696
- By:
- Publication type:
- Article
Real‐world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 2, p. 1, doi. 10.1002/cam4.6953
- By:
- Publication type:
- Article
Surgical thromboprophylaxis and risk of bleeding: a health economics perspective.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02123-5
- By:
- Publication type:
- Article
Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2022, p. 1, doi. 10.1177/17534666221113647
- By:
- Publication type:
- Article
The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK).
- Published in:
- Therapeutic Advances in Respiratory Disease, 2022, p. 1, doi. 10.1177/17534666211070139
- By:
- Publication type:
- Article
Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e360, doi. 10.1093/oncolo/oyad324
- By:
- Publication type:
- Article
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trial.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 4, p. 1029, doi. 10.1007/s11136-023-03582-z
- By:
- Publication type:
- Article
Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β<sub>2</sub>-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.
- Published in:
- 2022
- By:
- Publication type:
- journal article